MedTech Terms
    The authoritative reference
    All terms
    Clinical & TrialsClinical Evidence

    Protocol Deviation

    Departure from the approved clinical investigation plan.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    A protocol deviation is any change, divergence, or departure from the study design or procedures defined in the clinical investigation plan that does not have prior IRB/EC approval.
    What the regulation says
    Regulatory bodies such as the FDA (21 CFR Part 312, Subpart D, and 21 CFR Part 812, Subpart C) and the EU MDR (Article 62 and Annex I, Section 2) mandate that clinical investigations adhere to approved protocols. Protocol deviations, particularly those impacting subject safety, rights, well-being, or data reliability, must be reported to the Institutional Review Board (IRB) or Ethics Committee (EC) and the study sponsor. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E6(R2) guideline for Good Clinical Practice (GCP) also emphasizes the importance of protocol adherence and the proper documentation and reporting of deviations.

    What this means in practice

    Significant deviations affecting subject safety, rights, welfare, or data integrity must be reported to the IRB/EC and sponsor. Trends in deviations indicate a need for site retraining or protocol amendment.

    Examples

    • A clinical research coordinator administers a study drug at a dose slightly different from that specified in the protocol for one patient, without prior approval.
    • A subject in a clinical trial misses a scheduled follow-up visit, and the visit window specified in the protocol is exceeded.
    • An investigator enrolls a subject who meets most, but not all, of the pre-defined inclusion criteria outlined in the clinical investigation plan.
    Common pitfalls
    • •Failing to document minor deviations can obscure patterns indicating systemic issues or protocol flaws.
    • •Not assessing the impact of a deviation on subject safety or data integrity can lead to overlooking serious risks.
    • •Delaying the reporting of significant deviations can result in non-compliance and compromise study validity.
    • •Ignoring repeated deviations at a site may indicate inadequate training or a need for protocol clarification rather than isolated incidents.
    • •Misinterpreting which deviations require immediate reporting can lead to under-reporting or unnecessary administrative burdens.

    Frequently asked questions

    A protocol deviation is an unplanned departure from the approved protocol, while a protocol amendment is a formal, planned change to the protocol that receives prior IRB/EC approval before implementation.

    Cross-references

    Part of

    A larger framework or document this term belongs to.

    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    ICH·2NIH·1
    1. 1
      ICH E6(R3) Guideline
      Verified
      ICHdatabase.ich.org
    2. 2
      ClinicalTrials.gov
      Verified
      NIHclinicaltrials.gov
    3. 3
      ICH Guidelines
      Verified
      ICHich.org

    Inline markers like [1] jump to the matching reference above.